Anthony Rowen-Brown

Gmail Outlook Google Apps Microsoft Office 365 Nginx Mobile Friendly YouTube Render

drug development biotechnology protein degradation biotechnology research targeted protein degradation tpd technology biopharmaceuticals drug discovery proteomics structural biology molecular modelling small molecules cancer therapeutics immune-oncology autoimmune diseases crispr/cas9 genome editing first-in-class drugs drugable properties clinical trials lead compound optimization protein engineering e3 ligases drug resistance molecular glues bifunctional degraders oral drug delivery therapeutic targets pharmaceutical innovation high-throughput screening pipeline development drug candidates translational studies preclinical studies inducers of degradation unmet medical needs cancer stem cells oncogenic transcription factors therapeutic regimens biotech expertise molecular characterization clinical development risk management investor relations healthcare innovation scientific advancement r&d strategy high-value targets drug screening capabilities pharmaceutical market health care health wellness & fitness hospital & health care